Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID-19 in the United Kingdom.

Quraishi, Mohammed Nabil; Segal, Jonathan P; Cooney, Rachel; Kennedy, Nicholas A; Ainley, Rachel; Sharma, Naveen; Bhala, Neeraj B; Brookes, Matthew J

Quraishi, Mohammed Nabil; Segal, Jonathan P; Cooney, Rachel; Kennedy, Nicholas A; Ainley, Rachel; Sharma, Naveen; Bhala, Neeraj B; Brookes, Matthew J.

Quraishi MN; Department of Gastroenterology, University Hospitals Birmingham, Birmingham, UK.
Segal JP; College of Medical Sciences, University of Birmingham, Birmingham, UK.
Cooney R; Department of Gastroenterology and Hepatology, St Mary's, London, UK.
Kennedy NA; Department of Gastroenterology, University Hospitals Birmingham, Birmingham, UK.
Ainley R; College of Medical Sciences, University of Birmingham, Birmingham, UK.
Sharma N; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Bhala NB; Crohn's & Colitis UK, Hatfield, UK.
Brookes MJ; Department of Gastroenterology, University Hospitals Birmingham, Birmingham, UK.

Aliment Pharmacol Ther ; 52(5): 937-939, 2020 Sep.

Article in English | MEDLINE | ID: covidwho-714089

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Aliment Pharmacol Ther Journal subject: Pharmacology / Gastroenterology / Drug Therapy Year: 2020 Document Type: Article Affiliation country: Apt.15951

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google